Transmission reduction, health benefits, and upper-bound costs of interventions to improve retention on antiretroviral therapy: a combined analysis of three …

A Bershteyn, L Jamieson, HY Kim, I Platais… - The Lancet Global …, 2022 - thelancet.com
Background In this so-called treat-all era, antiretroviral therapy (ART) interruptions contribute
to an increasing proportion of HIV infections and deaths. Many strategies to improve …

Dropout and re-enrollment: implications for epidemiological projections of treatment programs

DJ Klein, A Bershteyn, PA Eckhoff - Aids, 2014 - journals.lww.com
Objective: EMOD-HIV v0. 8 has been used to estimate the potential impact of expanding
treatment guidelines to allow earlier initiation of antiretroviral therapy (ART) in sub-Saharan …

Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 …

JW Eaton, NA Menzies, J Stover… - The Lancet Global …, 2014 - thelancet.com
Background New WHO guidelines recommend initiation of antiretroviral therapy for HIV-
positive adults with CD4 counts of 500 cells per μL or less, a higher threshold than was …

Maximizing antiretroviral therapy in developing countries: the dual challenge of efficiency and quality

CJL Murray - JAMA, 2015 - jamanetwork.com
The rapid scale-up of antiretroviral therapy (ART) has been one of the great achievements of
global health in the last decade. Declines in deaths from human immunodeficiency virus …

Cost-effectiveness of population-level expansion of highly active antiretroviral treatment for HIV in British Columbia, Canada: a modelling study

B Nosyk, JE Min, VD Lima, RS Hogg, JSG Montaner - The lancet HIV, 2015 - thelancet.com
Background Widespread HIV screening and access to highly active antiretroviral treatment
(ART) were cost effective in mathematical models, but population-level implementation has …

[HTML][HTML] Impact and cost-effectiveness of hypothetical strategies to enhance retention in care within HIV treatment programs in East Africa

J Kessler, K Nucifora, L Li, L Uhler, S Braithwaite - Value in Health, 2015 - Elsevier
Objectives Attrition from care among HIV infected patients can lead to poor clinical
outcomes. Our objective was to evaluate hypothetical interventions seeking to improve …

Retention and mortality on antiretroviral therapy in sub‐Saharan Africa: collaborative analyses of HIV treatment programmes

AD Haas, E Zaniewski, N Anderegg… - Journal of the …, 2018 - Wiley Online Library
Abstract Introduction By 2020, 90% of all people diagnosed with HIV should receive long‐
term combination antiretroviral therapy (ART). In sub‐Saharan Africa, this target is …

HIV treatment as prevention: systematic comparison of mathematical models of the potential impact of antiretroviral therapy on HIV incidence in South Africa

JW Eaton, LF Johnson, JA Salomon… - PLoS …, 2012 - journals.plos.org
Background Many mathematical models have investigated the impact of expanding access
to antiretroviral therapy (ART) on new HIV infections. Comparing results and conclusions …

The survival benefits of antiretroviral therapy in South Africa

MD April, R Wood, BK Berkowitz… - The Journal of …, 2014 - academic.oup.com
Background. We sought to quantify the survival benefits attributable to antiretroviral therapy
(ART) in South Africa since 2004. Methods. We used the Cost-Effectiveness of Preventing …

The need for second-line antiretroviral therapy in adults in sub-Saharan Africa up to 2030: a mathematical modelling study

J Estill, N Ford, L Salazar-Vizcaya, AD Haas… - The Lancet …, 2016 - thelancet.com
Background The number of patients in need of second-line antiretroviral drugs is increasing
in sub-Saharan Africa. We aimed to project the need of second-line antiretroviral therapy in …